Cresco Labs Inc.
CRLBF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $472 | $182 | $254 | $319 |
| - Cash | $45 | $147 | $155 | $138 |
| + Debt | $581 | $631 | $646 | $640 |
| Enterprise Value | $1,007 | $666 | $744 | $821 |
| Revenue | $165 | $164 | $166 | $174 |
| % Growth | 0.8% | -1.3% | -5% | – |
| Gross Profit | $79 | $83 | $79 | $83 |
| % Margin | 48.1% | 50.9% | 47.4% | 47.3% |
| EBITDA | $20 | $31 | $29 | $32 |
| % Margin | 12% | 18.7% | 17.8% | 18.6% |
| Net Income | -$17 | -$16 | -$14 | -$4 |
| % Margin | -10.3% | -10% | -8.7% | -2.5% |
| EPS Diluted | -0.048 | -0.046 | -0.041 | -0.013 |
| % Growth | -3% | -12.2% | -226.2% | – |
| Operating Cash Flow | $6 | $9 | $30 | $29 |
| Capital Expenditures | -$8 | -$13 | -$7 | -$3 |
| Free Cash Flow | -$1 | -$4 | $23 | $26 |